Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Short Interest Down 76.3% in May

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a significant decrease in short interest in the month of May. As of May 15th, there was short interest totaling 792 shares, a decrease of 76.3% from the April 30th total of 3,341 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average daily volume of 17,047 shares, the short-interest ratio is presently 0.0 days.

Invesco Pharmaceuticals ETF Stock Down 0.8%

NYSEARCA:PJP traded down $0.86 on Friday, reaching $109.63. 4,873 shares of the company’s stock were exchanged, compared to its average volume of 35,898. The firm has a market capitalization of $358.49 million, a price-to-earnings ratio of 15.59 and a beta of 0.46. The business has a fifty day moving average of $105.06 and a 200-day moving average of $105.63. Invesco Pharmaceuticals ETF has a 52-week low of $78.77 and a 52-week high of $110.81.

Institutional Trading of Invesco Pharmaceuticals ETF

Institutional investors and hedge funds have recently bought and sold shares of the business. Fifth Third Bancorp purchased a new stake in Invesco Pharmaceuticals ETF during the first quarter worth about $36,000. Global Assets Advisory LLC purchased a new stake in Invesco Pharmaceuticals ETF during the first quarter worth about $42,000. IFP Advisors Inc increased its stake in Invesco Pharmaceuticals ETF by 31.3% during the fourth quarter. IFP Advisors Inc now owns 440 shares of the company’s stock worth $46,000 after purchasing an additional 105 shares during the period. International Assets Investment Management LLC purchased a new stake in Invesco Pharmaceuticals ETF during the fourth quarter worth about $64,000. Finally, Rockefeller Capital Management L.P. increased its stake in shares of Invesco Pharmaceuticals ETF by 20.5% during the fourth quarter. Rockefeller Capital Management L.P. now owns 1,230 shares of the company’s stock worth $129,000 after buying an additional 209 shares during the period.

Invesco Pharmaceuticals ETF Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types.